Your browser doesn't support javascript.
loading
The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer.
Gori, Stefania; Inno, Alessandro; Fiorio, Elena; Foglietta, Jennifer; Ferro, Antonella; Gulisano, Marcella; Pinotti, Graziella; Gubiotti, Marta; Cavazzini, Maria Giovanna; Turazza, Monica; Duranti, Simona; De Simone, Valeria; Iezzi, Laura; Bisagni, Giancarlo; Spazzapan, Simon; Cavanna, Luigi; Saggia, Chiara; Bria, Emilio; Cretella, Elisabetta; Vici, Patrizia; Santini, Daniele; Fabi, Alessandra; Garrone, Ornella; Frassoldati, Antonio; Amaducci, Laura; Saracchini, Silvana; Evangelisti, Lucia; Barni, Sandro; Gamucci, Teresa; Mentuccia, Lucia; Laudadio, Lucio; Zoboli, Alessandra; Marchetti, Fabiana; Bogina, Giuseppe; Lunardi, Gianluigi; Boni, Luca.
Afiliación
  • Gori S; Department of Oncology, Ospedale Sacro Cuore don Calabria, Negrar-Verona, Italy.
  • Inno A; Department of Oncology, Ospedale Sacro Cuore don Calabria, Negrar-Verona, Italy.
  • Fiorio E; Unit of Oncology, Ospedale Civile Maggiore, Verona, Italy.
  • Foglietta J; Medical Oncology, Azienda Ospedaliera di Perugia, Perugia, Italy.
  • Ferro A; Medical Oncology, Ospedale Santa Chiara, Trento, Italy.
  • Gulisano M; Medical Oncology, Ospedale S. Bortolo, Vicenza, Italy.
  • Pinotti G; Department of Oncology, Ospedale di Circolo and University of Insubria, Varese, Italy.
  • Gubiotti M; Medical Oncology, Ospedale Civile di Macerata, Macerata, Italy.
  • Cavazzini MG; Unit of Hematology and Oncology, AO Carlo Poma, Mantova, Italy.
  • Turazza M; Department of Oncology, Ospedale Sacro Cuore don Calabria, Negrar-Verona, Italy.
  • Duranti S; Department of Oncology, Ospedale Sacro Cuore don Calabria, Negrar-Verona, Italy.
  • De Simone V; Medical Oncology, Ospedale San Donato, Arezzo, Italy.
  • Iezzi L; Medical Oncology, Ospedale SS Annunziata, Chieti, Italy.
  • Bisagni G; Medical Oncology, Breast Unit, Arcispedale S. Maria Nuova, Reggio Emilia, Italy.
  • Spazzapan S; Medical Oncology, C.R.O.-I.R.C.C.S., Aviano-Pordenone, Italy.
  • Cavanna L; Department of Oncology and Hematology, Ospedale Guglielmo da Saliceto, Piacenza, Italy.
  • Saggia C; Medical Oncology, Ospedale Maggiore della Carità, Novara, Italy.
  • Bria E; Department of Medicine, Medical Oncology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
  • Cretella E; Medical Oncology, Azienda Sanitaria dell'Alto Adige, Bolzano, Italy.
  • Vici P; Division of Medical Oncology B, Regina Elena National Cancer Institute, Roma, Italy.
  • Santini D; Department of Medical Oncology, Campus Bio-Medico University, Roma, Italy.
  • Fabi A; Division of Medical Oncology A, Regina Elena National Cancer Institute, Roma, Italy.
  • Garrone O; Division of Medical Oncology, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy.
  • Frassoldati A; Medical Oncology, University Hospital, Ferrara, Italy.
  • Amaducci L; Medical Oncology, Ospedale per gli Infermi, Faenza-Ravenna, Italy.
  • Saracchini S; Medical Oncology, Ospedale Santa Maria degli Angeli, Pordenone, Italy.
  • Evangelisti L; Medical Oncology, ASL CN1, Saluzzo-Cuneo, Italy.
  • Barni S; Medical Oncology, Azienda Ospedaliera Treviglio, Treviglio-Bergamo, Italy.
  • Gamucci T; Medical Oncology Unit, ASL Frosinone, Frosinone, Italy.
  • Mentuccia L; Medical Oncology Unit, ASL Frosinone, Frosinone, Italy.
  • Laudadio L; Department of Oncology, Ospedale Floraspe Renzetti, Lanciano-Chieti, Italy.
  • Zoboli A; Medical Oncology, Ospedale San Sebastiano, Correggio-Reggio Emilia, Italy.
  • Marchetti F; Department of Oncology, Ospedale Sacro Cuore don Calabria, Negrar-Verona, Italy.
  • Bogina G; Pathology, Ospedale Sacro Cuore don Calabria, Negrar-Verona, Italy.
  • Lunardi G; Department of Oncology, Ospedale Sacro Cuore don Calabria, Negrar-Verona, Italy.
  • Boni L; Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy.
PLoS One ; 10(9): e0136731, 2015.
Article en En | MEDLINE | ID: mdl-26340098

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma Ductal de Mama / Receptor ErbB-2 / Trastuzumab / Antineoplásicos Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma Ductal de Mama / Receptor ErbB-2 / Trastuzumab / Antineoplásicos Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos